Liver extracellular matrix scaffold transplantation
Liver extracellular matrix scaffold transplantation has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Apr 22, 2022: “Transplantation of SDF-1α-loaded liver extracellular matrix repopulated with autologous cells attenuated liver fibrosis in a rat model”.
1 paper studies it5 findingsUpdated
1 new paper in 30 daysSee all 1 papers on liver extracellular matrix scaffold transplantation
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Royan Institute
- Animals1
What did studies of liver extracellular matrix scaffold transplantation find?
5Studies of liver extracellular matrix scaffold transplantation measured 5 outcomes, among them small vessel formation, serum albumin and cell engraftment.
Small vessel formation
upin rats1
1 study
Small vessel formation
upin rats1
Liver extracellular matrix scaffold transplantation increases small vessel formation in rats with G-CSF therapy; compared with LEM-Tx and LEM-TxS.
“Small vessel formation in the LEM-TxSG group was significantly higher than the LEM-Tx and LEM-TxS groups.”
Animalswith G-CSF therapy; compared with LEM-Tx and LEM-TxSSDF-1α-loaded scaffoldliver1 mm3 scaffold4 weeks
EXCLI journal
Serum albumin
upin rats1
1 study
Serum albumin
upin rats1
Liver extracellular matrix scaffold transplantation increases serum albumin in rats with G-CSF therapy; compared with fibrotic control.
“was highest in the LEM-TxSG group, which was significantly more than the fibrotic group.”
Animalswith G-CSF therapy; compared with fibrotic controlSDF-1α-loaded scaffold1 mm3 scaffold4 weeks
EXCLI journal
Cell engraftment
upin rats1
1 study
Cell engraftment
upin rats1
Liver extracellular matrix scaffold transplantation increases cell engraftment in rats with G-CSF therapy; compared with LEM-Tx, LEM-TxS and LEM-TxG.
“the number of engrafted cells into the transplanted scaffold and ratio of albumin (Alb) positive cells per total incorporated cells were considerably higher in the LEM-TxSG group”
Animalswith G-CSF therapy; compared with LEM-Tx, LEM-TxS and LEM-TxGSDF-1α-loaded scaffoldliver1 mm3 scaffold4 weeks
EXCLI journal
Liver necrosis grade
downin rats1
1 study
Liver necrosis grade
downin rats1
Liver extracellular matrix scaffold transplantation decreases liver necrosis grade in rats (fibrotic liver; all experimental groups versus fibrotic control).
“Liver necrosis grade, and alanine transaminase (ALT) and aspartate transaminase (AST) levels dramatically reduced in all experimental groups compared to the control group.”
Animalsfibrotic liver; all experimental groups versus fibrotic controlliver4 weeks
EXCLI journal
Liver fibrosis stage
downin rats1
1 study
Liver fibrosis stage
downin rats1
Liver extracellular matrix scaffold transplantation decreases liver fibrosis stage in rats (fibrotic liver; with G-CSF therapy, SDF-1α loading alone, or G-CSF therapy alone).
“We found significant reduction in liver fibrosis stage in the LEM-TxSG, LEM-TxS and LEM-TxG groups compared to the control (fibrotic) group.”
Animalsfibrotic liver; with G-CSF therapy, SDF-1α loading alone, or G-CSF therapy aloneSDF-1α-loaded scaffoldliver1 mm3 scaffold4 weeks
EXCLI journal